CLN8 anticorps (N-Term)
-
- Antigène Voir toutes CLN8 Anticorps
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Épitope
- N-Term
-
Reactivité
- Humain, Chien, Cheval, Singe
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLN8 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- Human CLN8
- Homologie
- Percent identity by BLAST analysis: Human, Dog, Horse (100%).
- Purification
- Immunoaffinity purified
- Immunogène
-
Synthetic peptide from N-Terminus of human CLN8 (Q9UBY8, NP_061764). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Galago, Dog, Horse (100%), Gibbon, Panda (92%), Marmoset, Guinea pig (85%).
Type of Immunogen: Synthetic peptide - Isotype
- IgG
- Top Product
- Discover our top product CLN8 Anticorps primaire
-
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) antibody
CLN8 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 247-286) antibodyCLN8 Reactivité: Humain ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 201-286) antibodyCLN8 Reactivité: Humain, Rat WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p), ICC Hôte: Lapin Polyclonal unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 251-280), (C-Term) antibodyCLN8 Reactivité: Humain WB Hôte: Lapin Polyclonal RB35588 unconjugated
anti-Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) (AA 72-121) antibodyCLN8 Reactivité: Humain, Chien, Souris, Boeuf (Vache) WB Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:12500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled Water.
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Antigène
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
- Autre désignation
- CLN8 (CLN8 Produits)
- Synonymes
- anticorps mnd, anticorps C8orf61, anticorps EPMR, anticorps CLN8, transmembrane ER and ERGIC protein, anticorps ceroid-lipofuscinosis, neuronal 8, anticorps CLN8, anticorps Cln8
- Sujet
-
Name/Gene ID: CLN8
Synonyms: CLN8, EPMR, Protein CLN8, C8orf61 - ID gène
- 2055
- NCBI Accession
- NP_061764
- UniProt
- Q9UBY8
- Pathways
- Regulation of Cell Size, Dicarboxylic Acid Transport
-
